Impact Factor
4.18
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
74.83
876 total citations
h5-index
22
h5 depth signal
Cited share
100.0%
12 of 12
Total citations
876
Citation footprint
Metric signal
79.50
External metric anchor
Self-citation
0.1%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
15
Georgia
2
Canada
2
Citing Fields of Research
Virology
13
Hepatitis
7
Tropical Diseases
6
Antibiotic & Antibacterial Agents
6
Sexually Transmitted Diseases
5
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
51
Articles tracked across the journal lifetime
Indexed publication set
12
12 cited publications
Last 12 months
2
1.0 publications/month
Open access share
100.0%
2 OA publications in the last year
Leading citing country
United States
15 citing publications
Leading citing field
Virology
13 citing publications
Latest tracked publication
21 May 2026
10 recent records available
Coverage & Indexing History
v39nRR1, Jan. 26, 1989-
v39nRR1, Jan. 26, 1989-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Virology
Parasitology Studies
Bacteriology
Healthcare Policy
Health Education & Remote Healthcare
Issuing & Sponsoring Bodies
Contributor
Centers for Disease Control (U.S.)
Contributor
Centers for Disease Control (U.S.). Epidemiology Program Office
Contributor
Centers for Disease Control and Prevention (U.S.)
Broad Categories
Public Health
Vital Statistics
Sexually Transmitted Diseases
Reproductive Health
Virology
Hepatitis
Antibiotic & Antibacterial Agents
Bacteriology
MeSH Descriptors
Health Policy
Preventive Health Services
Public Health
United States
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.15585/mmwr.rr7402a1
Open DOI
Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response — United States, 2025
The 2025 CDC recommendations for tularemia antimicrobial treatment and prophylaxis updates the 2001 recommendations for treatment of naturally acquired tularemia as well as tularemia occurring as a result of a bioterrorism attack.
03
DOI 10.15585/mmwr.rr7401a1
Open DOI
Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025
CDC updates HIV nonoccupational postexposure prophylaxis recommendations Meta Keywords:
04
DOI 10.15585/mmwr.rr7306a1
Open DOI
CDC Program Evaluation Framework, 2024
This report updates the previous CDC Framework for Program Evaluation in Public Health by integrating major advancements, lessons learned, and current federal agency policies and practices.
05
DOI 10.15585/mmwr.rr7305a1
Open DOI
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season
This report provides new CDC recommendations for the upcoming flu season.
06
DOI 10.15585/mmwr.rr7303a1
Open DOI
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
This report describes updated recommendations for contraceptive use.
07
DOI 10.15585/mmwr.rr7304a1
Open DOI
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
This report describes new and revised recommendations for the use of specific contraceptive methods by people who have certain characteristics or medical conditions.
08
DOI 10.15585/mmwr.rr7302a1
Open DOI
CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024
This report describes a recommendation from CDC for clinicians to use doxy PEP to help reduce incidents of syphilis, chlamydia, and gonorrhea in populations at high risk for these infections.
09
DOI 10.15585/mmwr.rr7301a1
Open DOI
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
This report provides new CDC recommendations for tests that can support a diagnosis of syphilis.
10
DOI 10.15585/mmwr.rr7206a1
Open DOI
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
This report describes updated guidelines and recommendations for prevention and treatment of anthrax.
Bibliographical & Catalog Notes
Title from cover.
Each issue has also a distinctive title.
Issues for 1993- also contained in the CD-ROM: Morbidity and mortality weekly report (CD-ROM)
Also issued online.
Each no. issued by the Centers for Disease Control (later Centers for Disease Control and Prevention) or one of its centers, divisions, or programs.
v. 38, no. S-5 (June 16, 1989)-v. 38, no. S-9 (Dec. 29, 1989); v.39, no. RR-1 (Jan. 26, 1990)-Will not microfilm 20040413